JAMA Network Home
Sign In
Research Letter

Stapokibart for the Treatment of Refractory Palmoplantar Pustulosis

JAMA Dermatology 10.1001/jamadermatol.2026.0669

April 22, 2026 at 11:00 AM EDT

Read the full article

This case series study evaluates the effectiveness and safety of stapokibart in treating patients with refractory palmoplantar pustulosis.

Corresponding Authors: Zhenghui Wang, PhD (ehui4298@163.com), and Xiaoli Li PhD (anjala@163.com), The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2026.0669?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042226

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks